604 related articles for article (PubMed ID: 9685708)
1. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
[TBL] [Abstract][Full Text] [Related]
2. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
3. DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation.
Vogel EW; Nivard MJ; Ballering LA; Bartsch H; Barbin A; Nair J; Comendador MA; Sierra LM; Aguirrezabalaga I; Tosal L; Ehrenberg L; Fuchs RP; Janel-Bintz R; Maenhaut-Michel G; Montesano R; Hall J; Kang H; Miele M; Thomale J; Bender K; Engelbergs J; Rajewsky MF
Mutat Res; 1996 Jun; 353(1-2):177-218. PubMed ID: 8692191
[TBL] [Abstract][Full Text] [Related]
4. DNA damage and repair in somatic and germ cells in vivo.
Vogel EW; Natarajan AT
Mutat Res; 1995 Aug; 330(1-2):183-208. PubMed ID: 7623865
[TBL] [Abstract][Full Text] [Related]
5. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
6. International Commission for Protection Against Environmental Mutagens and Carcinogens. The subtlety of alkylating agents in reactions with biological macromolecules.
Vogel EW; Nivard MJ
Mutat Res; 1994 Feb; 305(1):13-32. PubMed ID: 7508544
[TBL] [Abstract][Full Text] [Related]
7. Qualitative and quantitative procedures for health risk assessment.
Lohman PH
Mutat Res; 1999 Jul; 428(1-2):237-54. PubMed ID: 10517997
[TBL] [Abstract][Full Text] [Related]
8. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
McGregor D
Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
[TBL] [Abstract][Full Text] [Related]
9. Genotoxic effects of inhaled ethylene oxide, propylene oxide and butylene oxide on germ cells: sensitivity of genetic endpoints in relation to dose and repair status.
Vogel EW; Nivard MJ
Mutat Res; 1998 Sep; 405(2):259-71. PubMed ID: 9748619
[TBL] [Abstract][Full Text] [Related]
10. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
12. Short-term tests for defining mutagenic carcinogens.
Waters MD; Stack HF; Jackson MA
IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
[TBL] [Abstract][Full Text] [Related]
13. Quantitative comparative mutagenesis in bacteria, mammalian cells, and animal-mediated assays. A convenient way of estimating genotoxic activity in vivo?
Mohn GR; van Zeeland AA
Mutat Res; 1985; 150(1-2):159-75. PubMed ID: 3889614
[TBL] [Abstract][Full Text] [Related]
14. Genetic activity profiles of anticancer drugs.
Jackson MA; Stack HF; Waters MD
Mutat Res; 1996 Aug; 355(1-2):171-208. PubMed ID: 8781583
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph Series.
Bartsch H; Malaveille C
Cell Biol Toxicol; 1989 Jun; 5(2):115-27. PubMed ID: 2766027
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
17. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
18. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
19. The in vivo genetic activity profile of the monofunctional nitrogen mustard 2-chloroethylamine differs drastically from its bifunctional counterpart mechlorethamine.
Wijen JP; Nivard MJ; Vogel EW
Carcinogenesis; 2000 Oct; 21(10):1859-67. PubMed ID: 11023544
[TBL] [Abstract][Full Text] [Related]
20. Comparison of carcinogenic and in vivo genotoxic potency estimates.
Sanner T; Dybing E
Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
